Anyo Labs Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $8M

  • Investors
  • 6

Anyo Labs General Information

Description

Developer of a drug discovery platform designed to accelerate the development of new medicines. The company offers a screening and scoring tool that accelerates and reduces risk with expert support in the early stages of research, enabling healthcare industry clients to cut down on the time and resources required to bring new drugs to market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Arvid Wallgren's Backe 20
  • 413 46 Gothenburg
  • Sweden
+46 073-332
Primary Industry
Drug Discovery
Corporate Office
  • Arvid Wallgren's Backe 20
  • 413 46 Gothenburg
  • Sweden
+46 073-332

Anyo Labs Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anyo Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 27-Jul-2026 $8M In Progress Generating Revenue
5. Accelerator/Incubator 24-Apr-2025 Completed Generating Revenue
4. Seed Round 30-May-2024 Completed Generating Revenue
3. Grant 08-May-2024 Completed Startup
2. Accelerator/Incubator 14-Dec-2023 Completed Startup
1. Seed Round 01-Mar-2023 Completed Startup
To view Anyo Labs’s complete valuation and funding history, request access »

Anyo Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Anyo Labs’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Anyo Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to accelerate the development of new medicines. The company offers a scr
Drug Discovery
Gothenburg, Sweden
5 As of 2026

Hong Kong, Hong Kong
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anyo Labs Competitors (4)

One of Anyo Labs’s 4 competitors is InSilico Medicine Cayman, a Formerly VC-backed company based in Hong Kong, Hong Kong.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSilico Medicine Cayman Formerly VC-backed Hong Kong, Hong Kong
Isomorphic Labs Venture Capital-Backed London, United Kingdom
OpenBench Venture Capital-Backed San Francisco, CA
Recursion AI Corporation Palo Alto, CA
To view Anyo Labs’s complete competitors history, request access »

Anyo Labs Patents

Anyo Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024151196-A1 Ligand candidate screen and prediction Inactive 11-Jan-2023

Anyo Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anyo Labs Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Swedish-American Chamber of Commerce - New York Accelerator/Incubator
CVX Ventures Venture Capital Minority
Vinnova Government
Sahlgrenska Science Park Accelerator/Incubator
Chalmers Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Anyo Labs FAQs

  • When was Anyo Labs founded?

    Anyo Labs was founded in 2022.

  • Where is Anyo Labs headquartered?

    Anyo Labs is headquartered in Gothenburg, Sweden.

  • What is the size of Anyo Labs?

    Anyo Labs has 5 total employees.

  • What industry is Anyo Labs in?

    Anyo Labs’s primary industry is Drug Discovery.

  • Is Anyo Labs a private or public company?

    Anyo Labs is a Private company.

  • What is the current valuation of Anyo Labs?

    The current valuation of Anyo Labs is .

  • What is Anyo Labs’s current revenue?

    The current revenue for Anyo Labs is .

  • How much funding has Anyo Labs raised over time?

    Anyo Labs has raised $530K.

  • Who are Anyo Labs’s investors?

    Swedish-American Chamber of Commerce - New York, CVX Ventures, Vinnova, Sahlgrenska Science Park, and Chalmers Ventures are 5 of 6 investors who have invested in Anyo Labs.

  • Who are Anyo Labs’s competitors?

    InSilico Medicine Cayman, Isomorphic Labs, OpenBench, and Recursion AI are competitors of Anyo Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process